Case Study: Accelerating a Clinical Trial for Patients with a Rare Disease
Having a genetics services partner throughout the clinical trial and pre- and post-market stages of rare disease drug development is an asset to pharmaceutical companies as well as to patients. As our client worked its way through the complex process of gaining FDA approval for the first-ever treatment for adults with the rare disease Acute …
Case Study: Accelerating a Clinical Trial for Patients with a Rare Disease Read More »
